Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Reader Login
Users Online :842
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2022| March  | Volume 59 | Issue 5  
    Online since March 24, 2022

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLES
Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Results from a Phase IV study in India
Prabhat S Malik, Vanita Noronha, Deepak Dabkara, Vamshi K Maddu, Senthil Rajappa, Sewanti Limaye, Ullas Batra
March 2022, 59(5):1-10
DOI:10.4103/ijc.ijc_1374_21  
  1,004 606 -
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer
Kumar Prabhash, Bivas Biswas, Sachin Khurana, Ullas Batra, Ghanashyam Biswas, Suresh Hariram Advani, Prabrajya N Mohapatra, Senthil Rajappa, Ajay Sharma, Shekhar Patil, Palanki Satya Dattatreya, Rakesh Roy, Sachin Almel, Gautam Goyal, Narayanankutty Warrier
March 2022, 59(5):11-18
DOI:10.4103/ijc.ijc_438_21  
  691 157 -
REVIEW ARTICLES
Expert survey on management of prostate cancer in India: Real-world insights into practice patterns
Ganesh Bakshi, Hemant Tongaonkar, Sanjai Addla, Santosh Menon, Aditya Pradhan, Abhay Kumar, Abhijit Bapat, Adwaita Gore, Amit Joshi, Anand Raja, Anil Bradoo, Anita Ramesh, Anup Kumar, Archi Agrawal, Asawari Ambekar, Ashish Joshi, Ashish Singh, Bhupendra Pal Singh, Deepak Dabkara, Dhiraj Khadakban, Gagan Gautam, Gagan Prakash, Harvinder Singh Pahwa, Hemant Kumar Goel, Jagdeesh Kulkarni, Jeeban Jyoti Mishra, Kaushal Patel, Mahendra Pal, Percy Jal Chibber, Priya Tiwari, Radheshyam Naik, SK Raghunath, Rahul Krishnatry, Rajendra Shimpi, Rakesh Sharma, Rakesh Taran, Sameer Trivedi, Sanjay Nabar, Sanjoy Surekha, Satish Kumar, Satyakam Krishna Sawaimoon, Shailesh Raina, Srivatsa Narasimha, Suresh Advani, Syed Mohammed Ghouse, Vamshi Krishna Muddu, Vashishth Maniar, Vivek Venkat, Vedang Murthy
March 2022, 59(5):19-45
DOI:10.4103/ijc.ijc_1145_21  
  613 90 -
Evolving trends in lung cancer: Epidemiology, diagnosis, and management
Ramakant Deshpand, Manish Chandra, Amit Rauthan
March 2022, 59(5):90-105
DOI:10.4103/ijc.IJC_52_21  
  485 65 -
A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix)
Ankur Bahl, Senthil Rajappa, Sudhir Rawal, Ganesh Bakshi, Vedang Murthy, Ketaki Patil
March 2022, 59(5):160-174
DOI:10.4103/ijc.IJC_1415_20  
  423 75 -
Ideal sequencing in Stage IV epidermal growth factor receptor mutant Non–Small-Cell Lung Cancer
Meenu Walia, Manish K Singhal, Mangesh S Kamle
March 2022, 59(5):80-89
DOI:10.4103/ijc.IJC_50_21  
  408 52 -
BRCA mutations: Implications of genetic testing in ovarian cancer
Vineet Talwar, Amit Rauthan
March 2022, 59(5):56-67
DOI:10.4103/ijc.IJC_1394_20  
  404 56 -
Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety
T Raja, Rahul Sud, Sanjai Addla, Kalyan K Sarkar, PS Sridhar, Vikas Talreja, Minish Jain, Ketaki Patil
March 2022, 59(5):142-159
DOI:10.4103/ijc.IJC_65_21  
  374 61 -
Role of immunotherapy in metastatic EGFRm NSCLC: Is it relevant?
Boman Dhabhar, Tarini P Sahoo, JK Akshay
March 2022, 59(5):68-79
DOI:10.4103/ijc.IJC_49_21  
  364 53 -
Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC
Ullas Batra, Anusheel Munshi, Vedant Kabra, Gagandeep Momi
March 2022, 59(5):46-55
DOI:10.4103/ijc.IJC_51_21  
  357 52 -
A review on mechanisms of resistance to PARP inhibitors
Chirag Desai, Anand Pathak, Sewanti Limaye, Vashishth Maniar, Archita Joshi
March 2022, 59(5):119-129
DOI:10.4103/ijc.IJC_53_21  
  358 48 -
Management of human epidermal growth factor receptor 2–negative metastatic breast cancer: Role of poly adenosine diphosphate (ADP-ribose) polymerase inhibitors
Ashok Kumar Vaid, Chetan Deshmukh, Nitesh Rohatgi, Joydeep Ghosh
March 2022, 59(5):130-141
DOI:10.4103/ijc.IJC_30_21  
  318 37 -
Significance of emerging clinical oncology endpoints in support of overall survival
Shekar Patil, Vijay Agarwal, HS Drupad
March 2022, 59(5):106-118
DOI:10.4103/ijc.IJC_1417_20  
  286 32 -
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow